Presumably, the sinusoidal endothelium as well as the terminal hepatic vessels will be the target for antibody- and complement-mediated injury from the allograft in positive-crossmatch recipients

Presumably, the sinusoidal endothelium as well as the terminal hepatic vessels will be the target for antibody- and complement-mediated injury from the allograft in positive-crossmatch recipients. in 10 (4.3%) recipients, and detrimental in 196 (84.8%) recipients. From the 25 situations

Treatment or prophylaxis of thromboembolic disease in frail individuals with malignancy therefore requires a carefully tailored approach

Treatment or prophylaxis of thromboembolic disease in frail individuals with malignancy therefore requires a carefully tailored approach. or thromboembolism. Frailty in individuals with malignancy results from overlapping domains of ageing, Eastern Cooperative Oncology Group (ECOG) status, type of malignancy, poly-pharmacotherapy,